Skip to main content
Caplight Logo









Bioplastix

Bioplastix

Private
CuernavacaFrontier & Industrial Techhttps://bio-plastix.com/

Last Round

Seed

Jan 1, 2026

Total Funding Raised

$266,000

Company Overview

Bioplastix is a biotechnology company that develops genome-engineered biopolymer production technology to enable cost-efficient and scalable biodegradable materials.

Sector

Frontier & Industrial Tech

Verticals

Sustainable Materials, Biotechnology, Advanced Materials, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

synthetic biologybioplasticsprecision fermentationbiopolymermetabolic engineeringhome-compostable plasticsstrain optimizationsustainable materialsbiotechclean manufacturingindustrial biotechnologybio-manufacturingbioprocess engineeringgreen chemistrytech licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bioplastix Comparables

Compare Bioplastix with similar companies based on industry and business-model similarity.

Bioplastix comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Genecis Bioindustries
77%
PhaBuilder
74%
Bioplastech Ltd
66%

Bioplastix Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 1, 2026
GrantFeb 17, 2025
AcceleratorOct 7, 2024

Key People

Founding team and executive leadership

Gilberto Pérez Morales

Founder Chief Technology Officer

Founding Team

Karina Campos

Chief Executive Officer

Executive Team

Bioplastix Investors

Notable investors and investment history

Bioplastix investors
InvestorRounds
Start-Up ChileGrant
GRIDXAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 20, 2026

    Grew 33% QoQ from 9 to 12 employees.

  • Jun 4, 2025

    Grew 60% QoQ from 5 to 8 employees.

Bioplastix Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Bioplastix Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Bioplastix's valuation, stock price, and market status.

Firmographic Details

HeadquartersCuernavaca
Employee Range11
Year Founded2024
Last FundingJan 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?